ABRAMOVICH YEHOSHUA

PrivateCIK: 1443954
Location

TEL AVIV, L3

ABRAMOVICH YEHOSHUA enters SHL TELEMEDICINE LTD with 46.11K shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives
InsiderABRAMOVICH YEHOSHUACIK 1443954
IssuerSHL TELEMEDICINE LTDCIK 1166834
Director
Since Mar 2026
46.11K
Baseline shares
100% direct
46.11K
Direct ownership
1 position
18K
Derivative underlying
9 instruments
1
Security positions
All direct
Non-Derivative Holdings1

Ordinary Shares

Direct
Shares owned46.11K
Total
46.11K direct46.11K
Derivative Holdings9

Option

Direct
Underlying security
Ordinary Shares

Underlying shares

1.50K

Shares owned

N/A

Exercise price

17.02

Expiration

Exercise window

Option

Direct
Underlying security
Ordinary Shares

Underlying shares

1.50K

Shares owned

N/A

Exercise price

17.02

Expiration

Exercise window

Option

Direct
Underlying security
Ordinary Shares

Underlying shares

1.50K

Shares owned

N/A

Exercise price

17.02

Expiration

Exercise window

Option

Direct
Underlying security
Ordinary Shares

Underlying shares

1.50K

Shares owned

N/A

Exercise price

17.02

Expiration

Exercise window

Option

Direct
Underlying security
Ordinary Shares

Underlying shares

1.50K

Shares owned

N/A

Exercise price

17.02

Expiration

Exercise window

Option

Direct
Underlying security
Ordinary Shares

Underlying shares

1.50K

Shares owned

N/A

Exercise price

17.02

Expiration

Exercise window

Option

Direct
Underlying security
Ordinary Shares

Underlying shares

6K

Shares owned

N/A

Exercise price

17.02

Expiration

Exercise window

Option

Direct
Underlying security
Ordinary Shares

Underlying shares

1.50K

Shares owned

N/A

Exercise price

17.02

Expiration

Exercise window

Option

Direct
Underlying security
Ordinary Shares

Underlying shares

1.50K

Shares owned

N/A

Exercise price

17.02

Expiration

Exercise window

Total

Underlying

18K

Owned

0.00

ABRAMOVICH YEHOSHUA — Initial Ownership Disclosure (Form 3) Filed Mar 25, 2026 | Finecho